About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 502 record(s)
Req # A-2021-000346
Adverse Drug Reaction (ADR) for INFLUENZA VACCINE TRIVALENT. Report number: 000930953.Organization: Health Canada
June 2021
Req # A-2020-000618
Adverse Reaction Reports (AERs). Report numbers: E2B_03074463, E2B_03074464, E2B_03074476, E2B_03074519.Organization: Health Canada
June 2021
Req # A-2021-000259
Adverse Drug Reaction (ADR). Report number: 000933400.Organization: Health Canada
June 2021
Req # A-2021-000266
Adverse Drug Reaction (ADR) for Gallium Citrate Ga-67. Report number: 000937683.Organization: Health Canada
June 2021
Req # A-2020-001908
Adverse Reaction Reports (AERs). Report numbers: 000679948, E2B_02650787, 000731072, 000911128.Organization: Health Canada
June 2021
Req # A-2020-001921
Adverse Reaction Reports (AERs) for Aripiprazole. Report numbers: E2B_03355369, E2B_03443822, E2B_03445915, E2B_03445916, E2B_03448510, E2B_03448514, E2B_03451400, E2B_03451981, E2B_03452241, E2B_03452248, E2B_03452300, E2B_03452316, E2B_03452593,…Organization: Health Canada
June 2021
Req # A-2020-001944
Adverse Reaction Reports (AERs) for Mesalazine. Report numbers: E2B_03524634, E2B_03627743, E2B_03590665, E2B_03524630, E2B_03530040, E2B_03635523, E2B_03580939, 930781, 932057, E2B_03538465, 930310, 933243, 931350, 931043, 930791, 930296, 931048,…Organization: Health Canada
June 2021
Req # A-2020-001922
Adverse Reaction Reports (AERs) for Aripiprazole. Report numbers: 000926298, E2B_03452094, E2B_03452133, E2B_03452262, E2B_03346324, E2B_03395953, E2B_03396613, E2B_03419070, E2B_03430224, E2B_03442688, E2B_03452584, E2B_03459138, E2B_03459143,…Organization: Health Canada
June 2021
Req # A-2020-001851
Adverse Reaction Reports (AERs). Report numbers: E2B_03434342, E2B_03436213, E2B_03442102, E2B_03458324, E2B_03460265, E2B_03467692, E2B_03471237, E2B_03478199, E2B_03478484, E2B_03479648, E2B_03480453, E2B_03480635, E2B_03481165, E2B_03481185,…Organization: Health Canada
June 2021
Req # A-2020-001429
Adverse Reaction Reports (AERs). Report numbers: E2B_02956799, E2B_02956801, E2B_02956802, E2B_02956803, E2B_02956804, E2B_02956805, E2B_02956807, E2B_02957187, E2B_02957853, E2B_02958256, E2B_02958375, E2B_02958410, E2B_02958512, E2B_02959491,…Organization: Health Canada
June 2021